Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading up 35 points (0.2%) at 16,753 as of Monday, June 2, 2014, 3:55 PM ET. The NYSE advances/declines ratio sits at 1,422 issues advancing vs. 1,555 declining with 186 unchanged.

The Health Services industry as a whole closed the day down 0.9% versus the S&P 500, which was unchanged. Top gainers within the Health Services industry included

Dynatronics

(

DYNT

), up 1.9%,

American Caresource Holdings

(

ANCI

), up 2.9%,

Electromed

(

ELMD

), up 1.7%,

Biocept

(

BIOC

), up 5.2% and

MGC Diagnostics

(

MGCD

), up 3.6%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Biocept

(

BIOC

) is one of the companies that pushed the Health Services industry higher today. Biocept was up $0.23 (5.2%) to $4.66 on average volume. Throughout the day, 16,119 shares of Biocept exchanged hands as compared to its average daily volume of 20,000 shares. The stock ranged in a price between $4.40-$4.66 after having opened the day at $4.45 as compared to the previous trading day's close of $4.43.

Biocept has a market cap of $19.7 million and is part of the health care sector. Shares are unchanged year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Highlights from TheStreet Ratings analysis on BIOC go as follows:

You can view the full analysis from the report here:

Biocept Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

Electromed

(

ELMD

) was up $0.02 (1.7%) to $1.20 on light volume. Throughout the day, 16,250 shares of Electromed exchanged hands as compared to its average daily volume of 26,500 shares. The stock ranged in a price between $1.16-$1.25 after having opened the day at $1.18 as compared to the previous trading day's close of $1.18.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy products. Electromed has a market cap of $9.1 million and is part of the health care sector. Shares are down 67.1% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates Electromed a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Electromed as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on ELMD go as follows:

  • ELECTROMED INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. Earnings per share have declined over the last two years. We anticipate that this should continue in the coming year. During the past fiscal year, ELECTROMED INC swung to a loss, reporting -$0.16 versus $0.02 in the prior year. For the next year, the market is expecting a contraction of 18.8% in earnings (-$0.19 versus -$0.16).
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 132.9% when compared to the same quarter one year ago, falling from -$0.43 million to -$1.00 million.
  • Current return on equity is lower than its ROE from the same quarter one year prior. This is a clear sign of weakness within the company. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, ELECTROMED INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • The share price of ELECTROMED INC has not done very well: it is down 14.00% and has underperformed the S&P 500, in part reflecting the company's sharply declining earnings per share when compared to the year-earlier quarter. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
  • The gross profit margin for ELECTROMED INC is rather high; currently it is at 68.31%. Despite the high profit margin, it has decreased significantly from the same period last year. Despite the mixed results of the gross profit margin, ELMD's net profit margin of -25.37% significantly underperformed when compared to the industry average.

You can view the full analysis from the report here:

Electromed Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Caresource Holdings

(

ANCI

) was another company that pushed the Health Services industry higher today. American Caresource Holdings was up $0.08 (2.9%) to $2.88 on light volume. Throughout the day, 596 shares of American Caresource Holdings exchanged hands as compared to its average daily volume of 8,100 shares. The stock ranged in a price between $2.85-$2.88 after having opened the day at $2.85 as compared to the previous trading day's close of $2.80.

American CareSource Holdings, Inc. provides access to a network of ancillary healthcare service providers in the United States. American Caresource Holdings has a market cap of $20.5 million and is part of the health care sector. Shares are up 86.0% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate American Caresource Holdings a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates American Caresource Holdings as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and poor profit margins.

Highlights from TheStreet Ratings analysis on ANCI go as follows:

  • AMERICAN CARESOURCE HLDGS's earnings per share declined by 25.0% in the most recent quarter compared to the same quarter a year ago. The company has suffered a declining pattern earnings per share over the past two years. During the past fiscal year, AMERICAN CARESOURCE HLDGS reported poor results of -$0.66 versus -$0.54 in the prior year.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Providers & Services industry. The net income has decreased by 24.7% when compared to the same quarter one year ago, dropping from -$1.15 million to -$1.44 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, AMERICAN CARESOURCE HLDGS's return on equity significantly trails that of both the industry average and the S&P 500.
  • The gross profit margin for AMERICAN CARESOURCE HLDGS is currently extremely low, coming in at 1.28%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -28.65% is significantly below that of the industry average.
  • The revenue fell significantly faster than the industry average of 16.8%. Since the same quarter one year prior, revenues fell by 34.1%. The declining revenue appears to have seeped down to the company's bottom line, decreasing earnings per share.

You can view the full analysis from the report here:

American Caresource Holdings Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.